Bioavailability of alcohol: role of gastric metabolism and its interaction with other drugs
- PMID: 7712617
- DOI: 10.1159/000171470
Bioavailability of alcohol: role of gastric metabolism and its interaction with other drugs
Abstract
In most individuals, only part of the imbibed alcohol reaches the systemic blood. With doses relevant to social drinking, this is due mainly to gastric first-pass metabolism of alcohol, which acts as a barrier against toxic alcohol blood levels. The activity of gastric alcohol dehydrogenase can account for a substantial fraction of this metabolism. Fasting, female gender, old age, dilution of alcoholic beverages, chronic alcohol consumption and still undetermined factors decrease the gastric metabolism of alcohol. Aspirin and some H2-receptor antagonists also inhibit this gastric activity. In subjects with documented first-pass metabolism, these drugs increase blood alcohol levels, especially after repeated small drinks, and may result in unexpected impairment to perform complex tasks, such as driving. Thus, patients treated with these drugs should be warned of this possible side effect.
Similar articles
-
Human gastric alcohol dehydrogenase: its inhibition by H2-receptor antagonists, and its effect on the bioavailability of ethanol.Alcohol Clin Exp Res. 1990 Dec;14(6):946-50. doi: 10.1111/j.1530-0277.1990.tb01843.x. Alcohol Clin Exp Res. 1990. PMID: 1982399
-
Is there an interaction between H2-antagonists and alcohol?Drug Metabol Drug Interact. 1998;14(3):123-45. doi: 10.1515/dmdi.1998.14.3.123. Drug Metabol Drug Interact. 1998. PMID: 10366990 Review.
-
H2-antagonists and alcohol. Do they interact?Drug Saf. 1994 Apr;10(4):271-80. doi: 10.2165/00002018-199410040-00001. Drug Saf. 1994. PMID: 7912509 Review.
-
First-pass metabolism of ethanol: its role as a determinant of blood alcohol levels after drinking.Hepatogastroenterology. 1992 Feb;39 Suppl 1:62-6. Hepatogastroenterology. 1992. PMID: 1349554 Review. No abstract available.
-
Histamine H2-receptor antagonists and gastric ethanol metabolism in man: effects on its bioavailability.Eur J Cancer Prev. 1992 Oct;1 Suppl 3:33-6. doi: 10.1097/00008469-199210003-00005. Eur J Cancer Prev. 1992. PMID: 1361393 Review. No abstract available.
Cited by
-
First-pass metabolism of alcohol. Absence of diurnal variation and its inhibition by cimetidine after evening meal.Dig Dis Sci. 1995 Oct;40(10):2091-7. doi: 10.1007/BF02208989. Dig Dis Sci. 1995. PMID: 7587772
-
Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.Clin Pharmacokinet. 1997 Nov;33(5):344-400. doi: 10.2165/00003088-199733050-00003. Clin Pharmacokinet. 1997. PMID: 9391747 Review.
-
Role of variability in explaining ethanol pharmacokinetics: research and forensic applications.Clin Pharmacokinet. 2003;42(1):1-31. doi: 10.2165/00003088-200342010-00001. Clin Pharmacokinet. 2003. PMID: 12489977 Review.
-
Combination drug use and risk for fetal harm.Alcohol Res Health. 2011;34(1):27-8. Alcohol Res Health. 2011. PMID: 23580037 Free PMC article. Review.
-
Medical risks for women who drink alcohol.J Gen Intern Med. 1998 Sep;13(9):627-39. doi: 10.1046/j.1525-1497.1998.cr187.x. J Gen Intern Med. 1998. PMID: 9754520 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources